annual working capital:
$879.80M+$531.71M(+152.75%)Summary
- As of today (May 29, 2025), VKTX annual working capital is $879.80 million, with the most recent change of +$531.71 million (+152.75%) on December 31, 2024.
- During the last 3 years, VKTX annual working capital has risen by +$678.05 million (+336.09%).
- VKTX annual working capital is now at all-time high.
Performance
VKTX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$846.45M-$33.35M(-3.79%)Summary
- As of today (May 29, 2025), VKTX quarterly working capital is $846.45 million, with the most recent change of -$33.35 million (-3.79%) on March 31, 2025.
- Over the past year, VKTX quarterly working capital has dropped by -$87.11 million (-9.33%).
- VKTX quarterly working capital is now -9.33% below its all-time high of $933.56 million, reached on March 31, 2024.
Performance
VKTX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
VKTX Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +152.8% | -9.3% |
| 3 y3 years | +336.1% | +365.0% |
| 5 y5 years | +217.9% | +215.9% |
VKTX Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +506.4% | -9.3% | +532.5% |
| 5 y | 5-year | at high | +506.4% | -9.3% | +532.5% |
| alltime | all time | at high | +4146.3% | -9.3% | +3195.1% |
VKTX Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $846.45M(-3.8%) |
| Dec 2024 | $879.80M(+152.8%) | $879.80M(-3.4%) |
| Sep 2024 | - | $910.96M(-1.1%) |
| Jun 2024 | - | $920.63M(-1.4%) |
| Mar 2024 | - | $933.56M(+168.2%) |
| Dec 2023 | $348.09M(+139.9%) | $348.09M(-5.4%) |
| Sep 2023 | - | $367.89M(-4.7%) |
| Jun 2023 | - | $385.89M(+188.4%) |
| Mar 2023 | - | $133.82M(-7.8%) |
| Dec 2022 | $145.09M(-28.1%) | $145.09M(-4.0%) |
| Sep 2022 | - | $151.09M(-8.4%) |
| Jun 2022 | - | $165.00M(-9.4%) |
| Mar 2022 | - | $182.03M(-9.8%) |
| Dec 2021 | $201.75M(-17.3%) | $201.75M(-5.3%) |
| Sep 2021 | - | $212.93M(-5.3%) |
| Jun 2021 | - | $224.79M(-5.1%) |
| Mar 2021 | - | $236.95M(-2.9%) |
| Dec 2020 | $243.97M(-11.8%) | $243.97M(-3.7%) |
| Sep 2020 | - | $253.42M(-3.1%) |
| Jun 2020 | - | $261.56M(-2.4%) |
| Mar 2020 | - | $267.90M(-3.2%) |
| Dec 2019 | $276.72M | $276.72M(-2.2%) |
| Sep 2019 | - | $283.06M(-1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $288.02M(-2.1%) |
| Mar 2019 | - | $294.22M(-1.1%) |
| Dec 2018 | $297.58M(+2155.4%) | $297.58M(-1.4%) |
| Sep 2018 | - | $301.87M(+115.4%) |
| Jun 2018 | - | $140.15M(+93.6%) |
| Mar 2018 | - | $72.39M(+448.7%) |
| Dec 2017 | $13.19M(+76.0%) | $13.19M(+590.2%) |
| Sep 2017 | - | $1.91M(-70.8%) |
| Jun 2017 | - | $6.54M(-42.1%) |
| Mar 2017 | - | $11.29M(+50.6%) |
| Dec 2016 | $7.50M(-43.3%) | $7.50M(-21.4%) |
| Sep 2016 | - | $9.55M(-24.1%) |
| Jun 2016 | - | $12.57M(+22.7%) |
| Mar 2016 | - | $10.24M(-22.5%) |
| Dec 2015 | $13.22M(-160.8%) | $13.22M(+0.1%) |
| Sep 2015 | - | $13.21M(-24.1%) |
| Jun 2015 | - | $17.39M(-163.6%) |
| Mar 2015 | - | -$27.35M(+25.8%) |
| Dec 2014 | -$21.74M(<-9900.0%) | -$21.74M(-5.7%) |
| Jun 2014 | - | -$23.05M(+6485.4%) |
| Mar 2014 | - | -$350.00K |
| Dec 2013 | $52.10K(-195.8%) | - |
| Dec 2012 | -$54.40K | - |
FAQ
- What is Viking Therapeutics annual working capital?
- What is the all time high annual working capital for Viking Therapeutics?
- What is Viking Therapeutics annual working capital year-on-year change?
- What is Viking Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Viking Therapeutics?
- What is Viking Therapeutics quarterly working capital year-on-year change?
What is Viking Therapeutics annual working capital?
The current annual working capital of VKTX is $879.80M
What is the all time high annual working capital for Viking Therapeutics?
Viking Therapeutics all-time high annual working capital is $879.80M
What is Viking Therapeutics annual working capital year-on-year change?
Over the past year, VKTX annual working capital has changed by +$531.71M (+152.75%)
What is Viking Therapeutics quarterly working capital?
The current quarterly working capital of VKTX is $846.45M
What is the all time high quarterly working capital for Viking Therapeutics?
Viking Therapeutics all-time high quarterly working capital is $933.56M
What is Viking Therapeutics quarterly working capital year-on-year change?
Over the past year, VKTX quarterly working capital has changed by -$87.11M (-9.33%)